Drawing for BIO CRYST

USPTO serial 87748718

BIO CRYST

Reviewed by CopyMark Law Group

Reg. 5549799Status 702Registered
Filing date
Status date
Registration date
Aug 28, 2018
Examiner
MILLER, JUSTIN T
Law office
TMO LAW OFFICE 114

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BIO CRYST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erica L. Han

Erica L. Han Ropes & Gray LLPPrudential Tower, 800 Boylston StreetBoston, MA 02199-3600United States

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseasesACTIVEJan 8, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 3, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 2, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 19, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 19, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 19, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 18, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Aug 28, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 3, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 21, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 21, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 21, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 6, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 6, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 28, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 12, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 12, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 12, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 3, 2018ALIEASSIGNED TO LIE—
Apr 26, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 16, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Apr 16, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 16, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 16, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 13, 2018DOCKASSIGNED TO EXAMINER—
Jan 24, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance